The Global Vaccines Innovation and Immunology Conference (GVX Immunology-2026) is pleased to welcome Rosa Visone, Associate Professor at the Dentistry and Biotechnology "G. d'Annunzio" University, Italy, as an invited speaker.
Prof. Rosa Visone will deliver an Oral
Presentation (In-Person) during the conference, taking place September
21–23, 2026, in London, UK, with online participation available.
Presentation
Topic
Her
presentation will focus on the role of miR-181b in antitumor immunity and
chronic lymphocytic leukemia (CLL), highlighting its potential implications
for the development of vaccine-based therapeutic strategies.
Prof.
Visone's research focuses on the molecular pathogenesis and immune regulation
of CLL, particularly the role of microRNAs. Her work has contributed to
understanding miR-181b as a potential biomarker of CLL progression and its
involvement in enhancing antitumor T-cell responses.
Join
researchers, clinicians, immunologists, vaccinologists, and biotechnology
experts at GVX Immunology-2026 to explore the latest developments in
vaccines and immunology.
📅 September 21–23, 2026
📍
London, UK | Hybrid Event
🎤
Presentation: Oral Presentation (In-Person)
📩 Register Now: https://vaccines.miconferences.com/register
#GVXImmunology2026
#Vaccines #Immunology #CancerImmunology #CancerVaccines #CLL #MedicalResearch
No comments:
Post a Comment